Comparison of risk of hyperkalemia between SGLT2 inhibitors and DPP4-inhibitors in patients with type 2 diabetes

Authors: M Z Wu, Q W Ren, J Y Huang, Y K Tse, S Y Yu, L F Cheang, H L Li, Y H Chan, H F Tse, K H Yiu

Published: 2023-01-25

DOI: 10.1093/eurheartj/ehac779.121

Source: Full article